DJIA 16,181.95 123.60 0.77%
NASDAQ 4,677.51 41.40 0.89%
S&P 500 1,925.71 11.86 0.62%
market minute promo

27.12 0.17 (0.63%)

Quote as of


company name or ticker

Recent Quotes

CHRS $27.12 0.63%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.38
Previous Close $26.95
Daily Range $26.85 - $28.19
52-Week Range $12.27 - $38.10
Market Cap $1.0B
P/E Ratio -18.59
Dividend (Yield) $0.00 (0.0%)
Volume 19,275
Average Daily Volume 237,246
Current FY EPS -$5.98

Sector

Industry

Coherus BioSciences, Inc. (CHRS) Description

Coherus BioSciences, Inc. Website: http://www.coherus.com/

News & Commentary Rss Feed

$1.5 Trillion Reasons to Invest in These Companies

Generic drugmakers are cutting healthcare costs and a bigger opportunity for investors could be on tap.

Coherus BioSciences Enters Oversold Territory (CHRS)

Put Impax, Akorn and Sagent on Your Watch List of Generics Targets

InsiderInsights.com Daily Round Up 8/3/15: VRX, EPD, ZINC, BOX

Looking For Diogenes' Portfolio Update: Cempra, Alder Biopharmaceuticals, And Others

Scanning The SA Family For Alpha: Sudburyjakes

Why Coherus BioSciences Inc. Shares Burst Today

Coherus BioSciences shares are dropping on news tied to a dilutive share offering.

This Market Could Grow 6250% in 10 Years

With the regulatory pathway cleared, the biosimilars market is poised to turn into a gold mine, growing up to 6,250% in 10 years. Here's where to stake your claim.

See More CHRS News...